Clinical trial
Oral Immunotherapy for Childhood Egg Allergy
NCT00461097 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00461097 |
|---|---|
| Title | Oral Immunotherapy for Childhood Egg Allergy |
| Official title | Oral Desensitization to Egg With Subsequent Induction of Tolerance for Egg-Allergic Children (CoFAR 3) |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Consortium of Food Allergy Research |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypersensitivity, Immediate Hypersensitivity, Food Hypersensitivity |
| Intervention type | Drug |
| Interventions | Egg oral immunotherapy, Control Group |
| Enrollment | 55 |
| Start date | May 1, 2007 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2013 |
| First posted | Apr 17, 2007 |
| Last update posted | Dec 13, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: